Business Context and Reporting Period
This Form 8-K Current Report was filed by AmerisourceBergen Corporation (now Cencora, Inc.) on January 16, 2015. The report addresses corporate governance changes, specifically the departure of a director and the appointment of a successor, stemming from the company's strategic relationship with Walgreens Boots Alliance.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and related party agreements rather than financial performance results.
Material Changes
- Director Resignation: Gregory D. Wasson resigned from the Board of Directors on January 9, 2015, following his retirement from Walgreen Co.
- Director Appointment: On January 16, 2015, the Board elected Ornella Barra to fill the vacancy. Ms. Barra serves until the next annual meeting in March 2015.
- Successor Designation: The appointment of Ms. Barra was made by Walgreens Boots Alliance, Inc. in accordance with the Shareholders Agreement, which grants them the right to designate a director when they hold at least 5% of the company's common stock.
Outlook, Risks, and Related Transactions
Strategic Relationship: The company maintains a multi-billion dollar primary pharmaceutical distribution arrangement with Walgreens and access to generic drugs through a joint venture with Walgreens Boots Alliance. Walgreens Boots Alliance is the successor in interest to Walgreens under these agreements.
Equity Rights and Governance:
- Current Ownership: Walgreens Boots Alliance and related entities (the "Investors") own approximately 5% of the company's common stock.
- Future Rights: Investors hold rights to purchase up to 19,859,795 shares in open market transactions and warrants for up to 45,393,824 shares (Warrant 1 at $51.50 and Warrant 2 at $52.50).
- Board Representation Triggers:
- Upon full exercise of Warrant 1 and acquisition of Initial Open Market Shares, Walgreens Boots Alliance may designate a second director.
- If ownership drops below 14% but remains above 5%, the right to designate two directors is reduced to one.
- If ownership drops below 5%, the right to designate any director is lost.
Investor Verification Checklist
- Verify the current share ownership percentage of Walgreens Boots Alliance to confirm ongoing board representation rights.
- Review the terms of the Framework Agreement and Shareholders Agreement (filed March 20, 2013) for details on the multi-billion dollar distribution contract.
- Monitor the exercise dates for Warrant 1 (March 18, 2016) and Warrant 2 (March 18, 2017) to assess potential future dilution and governance changes.
- Confirm the status of the joint venture regarding generic drug procurement.